Oaktree Acquisition Corp. III Life Sciences Unit
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in … Read more
Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) - Total Liabilities
Latest total liabilities as of September 2025: $8.25 Million USD
Based on the latest financial reports, Oaktree Acquisition Corp. III Life Sciences Unit (OACCU) has total liabilities worth $8.25 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Oaktree Acquisition Corp. III Life Sciences Unit - Total Liabilities Trend (2024–2024)
This chart illustrates how Oaktree Acquisition Corp. III Life Sciences Unit's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Oaktree Acquisition Corp. III Life Sciences Unit Competitors by Total Liabilities
The table below lists competitors of Oaktree Acquisition Corp. III Life Sciences Unit ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang Yuejian Intelligent Equipment Co Ltd
SHG:603095
|
China | CN¥661.41 Million |
|
Shanghai Xin Nanyang Co Ltd
SHG:600661
|
China | CN¥1.33 Billion |
|
Daewon Cable
KO:006340
|
Korea | ₩174.33 Billion |
|
PSMC CO. Ltd
KQ:024850
|
Korea | ₩46.05 Billion |
|
Kambi Group plc
PINK:KMBIF
|
USA | $33.48 Million |
|
Amazing Microelectronic
TWO:6411
|
Taiwan | NT$1.27 Billion |
|
Shanghai Research Institute of Building Sciences Group Co. Ltd A
SHG:603153
|
China | CN¥1.79 Billion |
Liability Composition Analysis (2024–2024)
This chart breaks down Oaktree Acquisition Corp. III Life Sciences Unit's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.22 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Oaktree Acquisition Corp. III Life Sciences Unit's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Oaktree Acquisition Corp. III Life Sciences Unit (2024–2024)
The table below shows the annual total liabilities of Oaktree Acquisition Corp. III Life Sciences Unit from 2024 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $7.75 Million | -- |